Plazomicin is active against metallo-β-lactamase-producing enterobacteriaceae

Open Forum Infectious Diseases

Volumn 6, Issue 4, 2019, Pages

  Serio, Alisa W ^a   Keepers, Tiffany ^a   Krause, Kevin M ^a  

^a Achaogen Inc   (United States)

Author keywords

Aminoglycoside; Metallo lactamase; Plazomicin

Indexed keywords

AMIKACIN; GENTAMICIN; METALLO BETA LACTAMASE; PLAZOMICIN; RNA 16S; TOBRAMYCIN;

AMINOGLYCOSIDE RESISTANCE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CARBAPENEM RESISTANT KLEBSIELLA PNEUMONIAE; CARBAPENEM-RESISTANT ENTEROBACTERIACEAE; CITROBACTER FREUNDII; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTION; ESCHERICHIA COLI; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MIC50; MINIMUM INHIBITORY CONCENTRATION; MORGANELLA MORGANII; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS; PROVIDENCIA RETTGERI; PROVIDENCIA STUARTII; PYELONEPHRITIS; URINARY TRACT INFECTION;

EID: 85066405813     PISSN: None     EISSN: 23288957     Source Type: Journal    
DOI: 10.1093/ofid/ofz123     Document Type: Article

References (9)

1. Cox G, Ejim L, Stogios PJ, et al. Plazomicin retains antibiotic activity against most aminoglycoside modifying enzymes. ACS Infect Dis 2018; 4:980-7.
2. Aggen JB, Armstrong ES, Goldblum AA, et al. Synthesis and spectrum of the neoglycoside ACHN-490. Antimicrob Agents Chemother 2010; 54:4636-42.
3. ZEMDRI® (plazomicin) Full Prescribing Information. South San Francisco, CA: Achaogen, Inc.; 2018.
4. Castanheira M, Davis AP, Mendes RE, et al. In vitro activity of plazomicin against gram-negative and gram-positive isolates collected from U.S. hospitals and comparative activities of aminoglycosides against carbapenem-resistant enterobacteriaceae and isolates carrying carbapenemase genes. Antimicrob Agents Chemother. 2018; 62:e00313-18.
5. Livermore DM, Mushtaq S, Warner M, et al. Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates. J Antimicrob Chemother 2011; 66:48-53.
6. Galani I, Souli M, Daikos GL, et al. Activity of plazomicin (ACHN-490) against MDR clinical isolates of Klebsiella pneumoniae, Escherichia coli, and Enterobacter spp. from Athens, Greece. J Chemother 2012; 24:191-4.
7. Galani I, Nafplioti K, Adamou P, et al; Study Collaborators. Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance. BMC Infect Dis 2019; 19:167.
8. Zhang Y, Kashikar A, Bush K. In vitro activity of plazomicin against β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE). J Antimicrob Chemother 2017; 72:2792-5.
9. Martins AF, Bail L, Ito CAS, et al. Antimicrobial activity of plazomicin against Enterobacteriaceae-producing carbapenemases from 50 Brazilian medical centers. Diagn Microbiol Infect Dis 2018; 90:228-32.